Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2009-11-2
pubmed:abstractText
Inhibition of BCR-ABL tyrosine kinase activity has evolved as a mainstay of therapy for patients with chronic myeloid leukemia. However, a fraction of leukemic cells persists under targeted therapy and can lead to disease progression on cessation of treatment.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19880777-10477735, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880777-11423618, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880777-11493466, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880777-11533706, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880777-11756187, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880777-11940594, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880777-12576334, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880777-12637609, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880777-14427847, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880777-14534339, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880777-14687625, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880777-15044640, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880777-15059881, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880777-15251980, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880777-15377577, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880777-15381773, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880777-15465012, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880777-15531465, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880777-15988530, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880777-15996937, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880777-16006570, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880777-16343892, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880777-16415354, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880777-16543472, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880777-16627755, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880777-16709930, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880777-16857811, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880777-16928819, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880777-16982851, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880777-17013383, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880777-17151364, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880777-17267394, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880777-18463677, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880777-4126434, http://linkedlifedata.com/resource/pubmed/commentcorrection/19880777-8666936
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1592-8721
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
94
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1528-36
pubmed:dateRevised
2010-9-28
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
ABC transporter A3 facilitates lysosomal sequestration of imatinib and modulates susceptibility of chronic myeloid leukemia cell lines to this drug.
pubmed:affiliation
Department Hematology and Oncology, Georg-August-University, Goettingen Robert-Koch-Str.40, 37075 Goettingen, Germany.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't